1. Treatment of patients with tyrosine kinase inhibitor (TKI)-naïve epidermal growth factor receptor (EGFR)-mutant non-small cell lung cancer (NSCLC) with ...
1. Dose-dense adjuvant chemotherapy involving sequential epirubicin/cyclophosphamide and docetaxel showed improved breast cancer recurrence-free survival and event-free survival compared to ...
1. Approximately 88% of patients with GD2-positive diffuse midline glioma or other progressive CNS tumours receiving C7R-GD2.CARTs had a partial ...
1. Unlu and colleagues compared RECTIFIER, a large language model (LLM), against human study staff to evaluate patient eligibility for ...
Half the individuals receiving the new CAR-T cell therapy achieved stable disease or better. Intratumoral, intraventricular, and intratumoral + intraventricular ...
1. Amongst hospitals with a cardiac surgery department, 11.5% participated actively in research trials of transcatheter mitral or tricuspid therapies. ...
1. The use of a type I KIT inhibitor, such as PLX9486, in combination with a type II inhibitor, such ...
Image: PD Human Ovarian Follicle 1. HbA1c and fasting plasma glucose (FPG) demonstrated low sensitivity in detecting pre-diabetes in ...
